We are live on
!
Find out more
KE
KLP Enterprises Portfolio holdings
AUM
$1.97M
This Fund
S&P 500
This Quarter
Est. Return
-31.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17M
AUM Growth
-$7.83M
(-32%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Celldex Therapeutics
CLDX
$2.76B
| $17M | 100% |
457,667
| – | – |
|
Similar funds
FFG
GFT
SCU
NPAM
ZCM
CM
6C
CCM
KLP Enterprises's Q2 2017 Portfolio in Review
As of Q2 2017, KLP Enterprises held 1 position worth $17M, down 32% from $24.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 0%. KLP Enterprises opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- KLP Enterprises's ten largest holdings make up 100% of its $17M portfolio in Q2 2017.
- KLP Enterprises opened 0 new positions and closed 0 in Q2 2017.
- KLP Enterprises's portfolio value fell 32% quarter-over-quarter to $17M.
Based on KLP Enterprises's 13F filing for Q2 2017, filed 10 Aug 2017.